Charles Schwab’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-452,777
| Closed | -$61.7M | – | 3427 |
|
2020
Q3 | $61.7M | Buy |
452,777
+107,966
| +31% | +$14.7M | 0.03% | 546 |
|
2020
Q2 | $33.3M | Buy |
344,811
+59,156
| +21% | +$5.72M | 0.02% | 834 |
|
2020
Q1 | $13.4M | Buy |
285,655
+5,187
| +2% | +$243K | 0.01% | 1271 |
|
2019
Q4 | $20.4M | Buy |
280,468
+4,122
| +1% | +$300K | 0.01% | 1193 |
|
2019
Q3 | $14.4M | Buy |
276,346
+42,495
| +18% | +$2.22M | 0.01% | 1363 |
|
2019
Q2 | $11.7M | Buy |
233,851
+40,695
| +21% | +$2.04M | 0.01% | 1492 |
|
2019
Q1 | $10M | Buy |
193,156
+8,088
| +4% | +$421K | 0.01% | 1583 |
|
2018
Q4 | $9.04M | Buy |
185,068
+1,624
| +0.9% | +$79.4K | 0.01% | 1521 |
|
2018
Q3 | $12M | Buy |
183,444
+16,303
| +10% | +$1.06M | 0.01% | 1515 |
|
2018
Q2 | $8.3M | Buy |
167,141
+66,598
| +66% | +$3.31M | 0.01% | 1716 |
|
2018
Q1 | $4.91M | Buy |
100,543
+6,185
| +7% | +$302K | ﹤0.01% | 1954 |
|
2017
Q4 | $3.97M | Buy |
94,358
+13,640
| +17% | +$574K | ﹤0.01% | 2039 |
|
2017
Q3 | $3.46M | Buy |
80,718
+23,172
| +40% | +$993K | ﹤0.01% | 2068 |
|
2017
Q2 | $754K | Buy |
57,546
+13,866
| +32% | +$182K | ﹤0.01% | 2556 |
|
2017
Q1 | $575K | Buy |
43,680
+2,394
| +6% | +$31.5K | ﹤0.01% | 2599 |
|
2016
Q4 | $535K | Buy |
41,286
+2,156
| +6% | +$27.9K | ﹤0.01% | 2626 |
|
2016
Q3 | $640K | Buy |
39,130
+10,472
| +37% | +$171K | ﹤0.01% | 2535 |
|
2016
Q2 | $356K | Buy |
28,658
+9,152
| +47% | +$114K | ﹤0.01% | 2717 |
|
2016
Q1 | $209K | Buy |
19,506
+306
| +2% | +$3.28K | ﹤0.01% | 2888 |
|
2015
Q4 | $282K | Buy |
+19,200
| New | +$282K | ﹤0.01% | 2881 |
|